Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 1
2011 1
2012 4
2013 2
2014 1
2015 3
2016 5
2018 2
2019 2
2020 6
2021 5
2022 2
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network).
Falcone M, Tiseo G, Carbonara S, Marino A, Di Caprio G, Carretta A, Mularoni A, Mariani MF, Maraolo AE, Scotto R, Dalfino L, Corbo L, Macera M, Medaglia AA, d'Errico ML, Gioè C, Sgroi C, Del Vecchio RF, Ceccarelli G, Albanese A, Buscemi C, Talamanca S, Raponi G, Foti G, De Stefano G, Franco A, Iacobello C, Corrao S, Morana U, Pieralli F, Gentile I, Santantonio T, Cascio A, Coppola N, Cacopardo B, Farcomeni A, Venditti M, Menichetti F; Advancing knowLedge on Antimicrobial Resistant Infections Collaboration Network (ALARICO Network). Falcone M, et al. Among authors: dalfino l. Clin Infect Dis. 2023 Jun 16;76(12):2059-2069. doi: 10.1093/cid/ciad100. Clin Infect Dis. 2023. PMID: 36801828
Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic.
Giannella M, Verardi S, Karas A, Abdel Hadi H, Dupont H, Soriano A, Santerre Henriksen A, Cooper A, Falcone M; ARES Study Group. Giannella M, et al. Open Forum Infect Dis. 2023 Jul 4;10(7):ofad329. doi: 10.1093/ofid/ofad329. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37496600 Free PMC article.
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study.
Cicco S, Vacca A, Albanese F, Susca N, Desantis V, Magistro A, Cazzato G, Cicco G, Sablone S, Cariddi C, Marozzi MS, Catena C, Brosolo G, Marcante S, Ingravallo G, Dalfino L, Lauletta G, Pappagallo F, Solimando AG, Grasso S, Maiorano E, Introna F, Sechi LA, Ria R. Cicco S, et al. Among authors: dalfino l. Intern Emerg Med. 2023 Oct;18(7):1981-1993. doi: 10.1007/s11739-023-03383-9. Epub 2023 Aug 17. Intern Emerg Med. 2023. PMID: 37592135 Free PMC article.
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study.
Bavaro DF, Papagni R, Belati A, Diella L, De Luca A, Brindicci G, De Gennaro N, Di Gennaro F, Romanelli F, Stolfa S, Ronga L, Mosca A, Pomarico F, Dell'Aera M, Stufano M, Dalfino L, Grasso S, Saracino A. Bavaro DF, et al. Among authors: dalfino l. Infect Dis Ther. 2023 Aug;12(8):2147-2163. doi: 10.1007/s40121-023-00854-6. Epub 2023 Sep 1. Infect Dis Ther. 2023. PMID: 37653122 Free PMC article.
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study.
Bavaro DF, Belati A, Diella L, Frallonardo L, Guido G, Papagni R, Pellegrino C, Brindicci G, De Gennaro N, Di Gennaro F, Denicolò S, Ronga L, Mosca A, Pomarico F, Dell'Aera M, Stufano M, Dalfino L, Grasso S, Saracino A. Bavaro DF, et al. Among authors: dalfino l. J Antimicrob Chemother. 2023 Sep 5;78(9):2175-2184. doi: 10.1093/jac/dkad215. J Antimicrob Chemother. 2023. PMID: 37428015
Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center Study.
Dalfino L, Stufano M, Bavaro DF, Diella L, Belati A, Stolfa S, Romanelli F, Ronga L, Di Mussi R, Murgolo F, Loconsole D, Chironna M, Mosca A, Montagna MT, Saracino A, Grasso S. Dalfino L, et al. Antibiotics (Basel). 2023 Jun 14;12(6):1048. doi: 10.3390/antibiotics12061048. Antibiotics (Basel). 2023. PMID: 37370367 Free PMC article.
45 results